1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals

BACKGROUND: The Antibody-mediated Prevention (AMP) trials (HVTN 704/HPTN 085 and HVTN 703/HPTN 081) are the first efficacy trials to evaluate whether VRC01, a broadly neutralizing antibody (bnAb) that targets CD4 binding site of HIV envelope, prevents HIV acquisition in uninfected individuals. In th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Edupuganti, Srilatha, Mgodi, Nyaradzo M, Karuna, Shelly, Andrew, Philip, Kochar, Nidhi, Marshall, Kyle, Decamp, Allan, Takuva, Simbarashe, Anderson, Maija, De La Grecca, Robert, Gomez Lorenzo, Margarita, Burns, David, Goepfert, Paul, McElrath, Julie, Casapia, Martin, Sanchez, Jorge, Mukwekwerere, Pamela G, Shava, Emily, Lazarus, Erica M, Hural, John, Mascola, John R, Cohen, Myron, Corey, Lawrence
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808666/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1135
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak